Navigation Links
Death in Biological Technology

Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board

BETHESDA, Md., April 17 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today regretfully announced the death of its Chair...

Ecologists propose first prevention for white-nose syndrome death in bats

White-nose syndrome (WNS) is a poorly understood condition that, in the two years since its discovery, has spread to at least seven northeastern states and killed as many as half a million bats. Now researchers have suggested the first step toward a measure that may help save the affected bats: pr...

Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)

QUEBEC, Feb. 11 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing of a patent application for the detection and treatment of a physiological disorder that most likely leads to sudden unexplainable death in epileptic patients during seizure. Vic...

"Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart

After a six-year battle with heart disease that included numerous medications, trips to the emergency room and surgery to implant a pacemaker, 40-year-old Jim Fijalkovich found himself in the Intensive Care Unit at an Ohio hospital. Both sides of his heart were dying and he was in desperate need ...

Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes

Common Genetic Variations Predict Patient Response to Novel Beta Blocker Therapy TORONTO, Sept. 22 /PRNewswire/ -- Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among he...

Warner Chilcott Reports the Death of Its Director James Andress

ST. DAVID'S, Bermuda, March 14 /PRNewswire-FirstCall/ -- It is with a profound sense of loss that Warner Chilcott Limited (Nasdaq: WCRX ) reports today that Mr. James G. Andress, a director of the Company, died on Tuesday, March 11, 2008. Roger Boissonneault, Chief Executive Officer, Presid...

Schiavo's death calls attention to ethical issues weighed at Bioethics Forum

In late April, at a private research center south of Madison, a group of scientists, academics and even religious leaders will gather to talk about the ethical choices presented by biotechnology's expanding knowledge of the human brain. Hovering over the forum will be the memory of Terri Schiavo....

RFID can be a matter of life and death in the medical world

Madison, Wis . - Radio frequency identification technology is often touted as a way to improve supply chain management. But in the health care world, the technology is bringing other, perhaps more important benefits: safety and security. "Everybody wants to focus on the supply chain now, and ...

Ethanol bill's death in Wisconsin ignores what's happening with our neighbors

In the same week that state senators in Wisconsin killed a bill to require gasoline in the state to include ethanol, policymakers in another Midwestern state were celebrating their latest step toward a more bio-based economy. Agri-business giant Louis Dreyfus Corp. announced it will build the...

In Situ Cell Death Detection Kit

The In Situ Cell Death Detection Kit has been designed as a precise, fast, and simple non radioactive technique to detect and quantify apoptotic cell death at the single-cell level in tissues. It is based on the s...

Quantification of Nucleosomes in Serum by the Cell Death Detection ELISAplus

Cell death as a counterpart to cell proliferation plays an essential role in the homeostasis of cell numbers in adult organisms, furthermore in eliminating cells damaged by irradiation, chemotherapeutic drugs, hyperthermi...

OncoGenex Reports Second Quarter 2009 Financial Results

...arm. The unadjusted hazard ratio (HR), a measure used to compare the death rates between treatment groups, was 0.61, representing a 39% lower rate of death for patients treated with OGX-011. - Preliminary results of a ...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

..., we are about results - bridging the gap between basic research and later stage drug development in humans. Alzheimer's is the fifth leading cause of death in the elderly and the third most costly disease overall. We're seeking to reduce the growing consequences this disease has on individuals and familie...

The Breast Cancer Therapeutics Market in Australia

...try was 164,814 in 2008. This figure is estimated to reach 304,511 patients by 2013. Globally, breast cancer is second to lung cancer as the cause of death among women. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) Initiatives such as the BreastScreen Australia program, whic...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

... Pneumonia (CAP) Community-acquired pneumonia (CAP) can be caused by a variety of bacteria and viruses and is the seventh most common cause of death in the United States. Bacterial CAP is most often caused by pathogens such as S. pneumoniae and H. influenzae . CAP affects approximately 5.6 milli...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...e drug is not yet approved for this or any other indication. About Community Acquired Pneumonia (CAP) CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenza...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

...ologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of ...

First genetically engineered malaria vaccine to enter human trials

...an and Canada, will be trialled in humans from early next year. Malaria kills more than one million people each year and destroys through premature death and disability the equivalent of at least 35 million years of healthy, productive human life every year. Professor Alan Cowman, head of the institu...

Sunesis Reports Financial Results for the Second Quarter 2009

... In the United States, ovarian cancer remains the leading cause of death from gynecologic malignancies and is the fifth leading cause of cancer death overall in women behind lung, breast, colorectal and pancreatic cancers. Ac...

Vi typhoid vaccine proves highly effective in young children

...o development and deployment of new vaccines primarily for people in developing countries. Typhoid fever remains an important cause of illness and death in the developing world, killing an estimated 216,000 to 600,000 people annually. Multidrug-resistant Salmonella typhi has spread to many parts of the...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... of these conditions or symptoms while taking Vyvanse. Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use. Talk to your health care provi...

Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent

...r the TAXUS Liberte Long Stent as compared to the TAXUS Express Stent control (1.3% vs. 6.3%, p=0.026). At two years, the composite measure of cardiac death or myocardial infarction showed a significant 63 percent reduction for the TAXUS Liberte Long Stent compared to the TAXUS Express Stent (3.5% vs. 9.4%...

Canadian researchers discover gene related to the appearance of aging

...ng brain development." The gene is one of six novel discoveries made to date through the AMGGI project. Among them, a gene related to sudden cardiac death in Newfoundland and Labrador and one linked to haemoglobin production. ...

New method may accelerate drug discovery for difficult diseases like Parkinson's

...s disease symptoms. In the Lindquist yeast model, the cells exhibit many of the hallmarks of cells in Parkinson's disease patients' brains, including death due to toxic overproduction of alpha-synuclein. Once the cyclic peptides were inserted into the model yeast cells, Kritzer switched the yeast into ...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

...ologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of ...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

...ke, osteoarthritis, sleep disorders and several types of cancers. According to The Obesity Society, obesity is the second leading cause of preventable death in the United States. The total direct and indirect cost attributed to overweight and obesity health issues exceeds $100 billion in the United States ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

...timated 246 million adults worldwide.(i,ii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes is the fifth leading cause of death by disease in the U.S. and results in approximately $174 billion per year in direct and indirect medical expenses.(iii) According to the Centers...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...he Year 2005: Percentage Breakdown by Cause of death -Heart Diseases, Cancer, Cerebrovascular disea...esponding Graph/Chart) II-17 Table 11: Cancer death Rates in the US (2007): Percentage Breakdown b...he Year 2005: Percentage Breakdown by Cause of death -Heart Diseases, Cancer, Cerebrovascular disea...

ArborGen and Senesco Announce Wood Quality Results

...logies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... any of these conditions or symptoms while taking Vyvanse. Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use. Talk to your health care provider ...

OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer

...urthermore, the unadjusted hazard ratio (HR), a measure used to compare the death rates between treatment groups, was 0.61, representing a 39% lower rate of death for patients treated with OGX-011. About OGX-011 OGX-011 is desig...

Healthy Advice Networks Announces Improved Patient Outcomes in Physicians' Offices with Healthy Advice Programs

...r as a major priority since there is such great potential to prevent cancer, save lives and diminish suffering. It's the third leading cause of cancer death and a majority of these deaths could have been prevented with early detection. We know that the more informed patients are, the better their outcomes ...

Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences

....D. Laboratory of Jodi M. Nunnari, Ph.D. University of California, Davis Mitochondrial division and cell death For full biographies and information regarding the fellows' research subjects, please visit www.pewlatinfellows...

Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease

...far, dimebon has been shown to inhibit brain cell death, potentially by stabilizing and improving mitochondrial function in a way that prevents neuron death and dysfunction. The dimebon mechanism is thought to be distinct from that of currently available Alzheimer's disease medications. In addition to...

New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease

...ential to provide coverage against the 13 most prevalent serotypes associated with pneumococcal disease (PD), the leading cause of vaccine-preventable death in children younger than five worldwide. The Phase 3 data presented at the 27th Annual Meeting of the European Society for Pediatric Infectious...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

...logies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of...

D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients

...rapeutic window. About Stroke Every year approximately 780,000 Americans have a new or recurrent stroke. The second most common cause of death worldwide, stroke is also the leading cause of serious long-term disability; 15% to 30% of stroke survivors experience permanent disability. According...

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

...ulates expression of many key genes important in cancer biology, including genes that regulate angiogenesis, cell metabolism, cell proliferation, cell death (apoptosis) and cell invasion. HIF-1 alpha protein is low in normal cells, but reaches high intracellular concentrations in a variety of cancers and i...

Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI

...cin Fidaxomicin is the first in a new class of antibiotics called macrocyclics, which inhibit the bacterial enzyme RNA polymerase, resulting in the death of Clostridium difficile . The narrow spectrum profile of fidaxomicin may eradicate Clostridium difficile selectively with minimal disruption to th...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... any of these conditions or symptoms while taking Vyvanse. Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use. Talk to your health care provider ...
Other Tags
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, featuring FPC,s touch ... 2015 that relate to sales of FPC1155 for this smartphone model ... for 2015. Jörgen Lantto, CEO of FPC, comments: " ... manufacturer in China and we are proud ... for Z1 , its first ...
(Date:8/6/2015)... and TELTOW, Germany , August 6, ... Conference, SensoMotoric Instruments (SMI) shows the world,s ... , based on Epson,s Moverio BT-200 see-through head ... With this new solution, unprecedented quality and efficiency is ... with context-sensitive displays. For the first time, professionals and ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
(Date:9/2/2015)... ... ... article published August 12 by International Business Times, a new bill was signed ... in cases meant to decide if a police officer used deadly or excessive force in ... and New York City that absolved police officers of charges in the deaths of two ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... from the Abraham and Mildred Goldstein Charitable Trust to establish the Abraham and ... gift comes six months after WCHN recruited nationally known gynecologic oncologist Thomas J. ...
(Date:9/2/2015)... ... 02, 2015 , ... In “Failure Lab: Weight Loss Surgery was Never the ... writer Akela Stanfield detailed her lifelong struggle with obesity that eventually led her to ... seen herself as someone who would lose weight through sheer self-control, the dawning realization ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healtec® LLC hired ... departure of Kristen Dietz, former Chief Operations Officer. Shaun Carpenter MD, FAPWCA, ... welcoming Mr. Salot: “ Stanley H. Salot Jr , our new President and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Density measurement is used in ... sample handling makes density measurements more efficient and error-free. The new METTLER TOLEDO ... workflow and the advantages compared to manual sample handling. , The Evolution of ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:Healtec® Announces Executive Leadership Change 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3
Other Contents